Significance of Clopidogrel Resistance Related to the Stent-Assisted Angioplasty in Patients with Atherosclerotic Cerebrovascular Disease

被引:19
作者
Rho, Gyoung-Jun [2 ]
Shin, Woo-Ram [2 ]
Kong, Tae-Sik [2 ]
Kim, Min-Sun [1 ]
Lee, Chang-Ju [1 ]
Lee, Byung-Hee [1 ]
机构
[1] Eulji Univ Hosp, Dept Radiol, Taejon 302799, South Korea
[2] Presbyterian Med Ctr, Dept Neurosurg, Jeonju, South Korea
关键词
Clopidogrel; Resistance; Neurointervention; Stent; DUAL ANTIPLATELET THERAPY; PERCUTANEOUS CORONARY INTERVENTION; ACUTE MYOCARDIAL-INFARCTION; PLATELET-AGGREGATION; RECEPTOR ANTAGONIST; DIABETES-MELLITUS; P2Y(12) RECEPTOR; ARTERY-DISEASE; DOUBLE-BLIND; INHIBITION;
D O I
10.3340/jkns.2011.50.1.40
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective : To evaluate the prevalence and risk factors of clopidogrel resistance, and association between thromboembolic complications and clopidogrel resistance in patient with stent-assisted angioplasty for atherosclerotic cerebrovascular disease. Methods : Between September 2006 and June 2008, clopidogrel resistance test was performed on 41 patients who underwent stent-assisted angioplasty for atherosclerotic cerebrovascular disease. It was performed before drug administration and about 12 hours after drug administration (loading dose : 300 mg, maintain dose : 75 mg). Two patients were excluded, and 41 patients were included (mean : 67.59 +/- 7.10 years, age range : 41-79). Among 41 patients, 18 patients had intracranial lesions, and 23 had extracranial lesions. We evaluated the prevalence, risk factors and complications related to clopidogrel resistance. Results : Twenty-one patients (51.2%) showed clopidogrel resistance [intracranial : 10 patients (55.6%), extracranial : 11 patients (47.8%)] and no clopidogrel resistance was seen in 20 patients. Hypercholesterolemia was an indepedent risk factor of clopidogrel resistance. Stent-assisted angioplasty was technically successful in all patients, but acute in-stent thrombosis occurred in 5 patients with intracranial lesions (4 patients with clopidogrel resistance and 1 without clopidogrel resistance). Acute thrombi were completely lysed after intra-arterial infusion of abciximab. Conclusion : There was relatively high prevalence of clopidogrel resistance in patients with atherosclerotic cerebrovascular disease. Hypercholesterolemia was an independent predictive factor of clopidogrel resistance. Acute in-stent thrombosis was more frequently seen in the clopidogrel resistant group. Therefore, clopidogrel resistance test should be performed to avoid thromboembolic complications related to stent-assisted angioplasty for atherosclerotic cerebrovascular disease, especially patients with hypercholeterolemia and intracranial lesion.
引用
收藏
页码:40 / 44
页数:5
相关论文
共 36 条
[1]   A randomized study assessing the impact of cilostazol on platelet function profiles in patients with diabetes mellitus and coronary artery disease on dual antiplatelet therapy: results of the OPTIMUS-2 study [J].
Angiolillo, Dominick J. ;
Capranzano, Piera ;
Goto, Shinya ;
Aslam, Mohammed ;
Desai, Bhaloo ;
Charlton, Ronald K. ;
Suzuki, Yoshie ;
Box, Lyndon C. ;
Shoemaker, Steven B. ;
Zenni, Martin M. ;
Guzman, Luis A. ;
Bass, Theodore A. .
EUROPEAN HEART JOURNAL, 2008, 29 (18) :2202-2211
[2]   Intravenous Platelet Blockade with Cangrelor during PCI. [J].
Bhatt, Deepak L. ;
Lincoff, A. Michael ;
Gibson, C. Michael ;
Stone, Gregg W. ;
McNulty, Steven ;
Montalescot, Gilles ;
Kleiman, Neal S. ;
Goodman, Shaun G. ;
White, Harvey D. ;
Mahaffey, Kenneth W. ;
Pollack, Charles V., Jr. ;
Manoukian, Steven V. ;
Widimsky, Petr ;
Chew, Derek P. ;
Cura, Fernando ;
Manukov, Ivan ;
Tousek, Frantisek ;
Jafar, M. Zubair ;
Arneja, Jaspal ;
Skerjanec, Simona ;
Harrington, Robert A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (24) :2330-2341
[3]   Interaction between statins and clopidogrel: is there anything clinically relevant [J].
Bhindi, R. ;
Ormerod, O. ;
Newton, J. ;
Banning, A. P. ;
Testa, L. .
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2008, 101 (12) :915-925
[4]   Inactivation of the human P2Y12 receptor by thiol reagents requires interaction with both extracellular cysteine residues, Cys17 and Cys270 [J].
Ding, ZR ;
Kim, S ;
Dorsam, RT ;
Jin, JG ;
Kunapuli, SP .
BLOOD, 2003, 101 (10) :3908-3914
[5]   The genetics of antiplatelet drug resistance [J].
Feher, G. ;
Feher, A. ;
Pusch, G. ;
Lupkovics, G. ;
Szapary, L. ;
Papp, E. .
CLINICAL GENETICS, 2009, 75 (01) :1-18
[6]   Clinical importance of aspirin and clopidogrel resistance [J].
Feher, Gergely ;
Feher, Andrea ;
Pusch, Gabriella ;
Koltai, Katalin ;
Tibold, Antal ;
Gasztonyi, Beata ;
Papp, Elod ;
Szapary, Laszlo ;
Kesmarky, Gabor ;
Toth, Kalman .
WORLD JOURNAL OF CARDIOLOGY, 2010, 2 (07) :171-186
[7]   Low response to clopidogrel is associated with cardiovascular outcome after coronary stent implantation [J].
Geisler, Tobias ;
Langer, Harald ;
Wydymus, Magdalena ;
Goehring, Katrin ;
Zuern, Christine ;
Bigalke, Boris ;
Stellos, Konstantinos ;
May, Andreas E. ;
Gawaz, Meinrad .
EUROPEAN HEART JOURNAL, 2006, 27 (20) :2420-2425
[8]   Preliminary experience with intravenous P2Y12 platelet receptor inhibition as an adjunct to reduced-dose alteplase during acute myocardial infarction:: Results of the Safety, Tolerability and Effect on Patency in Acute Myocardial Infarction (STEP-AMI) angiographic trial [J].
Greenbaum, Adam B. ;
Ohman, E. Magnus ;
Gibson, C. Michael ;
Borzak, Steven ;
Stebbins, Amanda L. ;
Lu, Mei ;
Le May, Michel R. ;
Stankowski, Jill E. ;
Emanuelsson, Hakan ;
Weaver, W. Douglas .
AMERICAN HEART JOURNAL, 2007, 154 (04) :702-709
[9]   Randomized Double-Blind Assessment of the ONSET and OFFSET of the Antiplatelet Effects of Ticagrelor Versus Clopidogrel in Patients With Stable Coronary Artery Disease The ONSET/OFFSET Study [J].
Gurbel, Paul A. ;
Bliden, Kevin P. ;
Butler, Kathleen ;
Tantry, Udaya S. ;
Gesheff, Tania ;
Wei, Cheryl ;
Teng, Renli ;
Antonino, Mark J. ;
Patil, Shankar B. ;
Karunakaran, Arun ;
Kereiakes, Dean J. ;
Parris, Cordel ;
Purdy, Drew ;
Wilson, Vance ;
Ledley, Gary S. ;
Storey, Robert F. .
CIRCULATION, 2009, 120 (25) :2577-U103
[10]   Recent developments in clopidogrel pharmacology and their relation to clinical outcomes [J].
Gurbel, Paul A. ;
Antonino, Mark J. ;
Tantry, Udaya S. .
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2009, 5 (08) :989-1004